Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc.（GBT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
gbt · 股价预测 · 29 位分析师（近3月）· FMP · 更新于 2023年12月4日
分析师评级与共识
基于过去 3 个月内 29 位华尔街分析师
Buy
29 位分析师
共识
评级分布
12 个月目标价
High
$110
Consensus
$60.38
-11.8% upside
Low
$36.00
Median: $59 · Last Close: $68.49
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$60.38
-11.8% upside
High Target
$110
60.6%
Low Target
$36
-47.4%
Current Price
$68.49
as of today
Based on analyst price targets, the GBT stock price prediction for the next 12 months ranges from $36 to $110. The consensus GBT price forecast of $60.38 implies -11.8% upside from the current price of $68.49.
短期股价预测
Ranging算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $68.60 | ↑ 0.16% |
1-day model range: $68.57–$68.63. Peak: $68.63 (+0.16%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GBT · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-08-19 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2022-08-09 | RBC Capital | Downgrade ↓ | Outperform→Perform |
| 2022-08-09 | SVB Leerink | Downgrade ↓ | Outperform→Perform |
| 2022-08-09 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2022-08-09 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2022-08-08 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2022-08-08 | Canaccord Genuity | Upgrade ↑ | Hold→Buy |
| 2022-08-08 | Stifel | Downgrade ↓ | Buy→Hold |
| 2022-08-08 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2022-06-28 | JP Morgan | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Global Blood Therapeutics, Inc. (GBT) stock. Of the recent 79 rating actions, 4 were upgrades and 12 were downgrades. 29 analysts currently cover GBT.
分析师推荐趋势
GBT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast GBT EPS of $— for the current fiscal year, based on estimates from 0 analysts. The GBT revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GBT 股价预测由两类独立数据源支撑：来自 29 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GBT 的共识目标价为 $60.38（-11.8% 上行空间），分析师共识为 Buy。
GBT 的短期预测（明日）为 $68.60（+0.16%）。
Global Blood Therapeutics, Inc. 在 NASDAQ 上市，代码 GBT。GBT 在 2027 年的整体展望偏积极，在覆盖分析师中约 62% 对应 Buy 共识。
常见问题
GBT 预测 · 8 个问题根据 29 位华尔街分析师，GBT 的 12 个月平均目标价为 $60.38，最高 $110.00、最低 $36.00。若有图表，中位目标价可在上方查看。相对当前价 $68.49，隐含约 -11.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.